Showing results (711-720 of 787) with videos related to

Sort By:
Pageof 79
Clinical Proteomics|August 29, 2023
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosisDorsa Sohaei, Simon Thebault, Lisa M Avery, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2013
Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionPunit Saraon, Daniela Cretu, Natasha Musrap, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survivalD Katsaros, H Yu, M A Levesque, et al.
Cancer Research|July 23, 2003
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancerGeorge M Yousef, Mary-Ellen Polymeris, Linda Grass, et al.
Clinical Chemistry|June 18, 2005
Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluidsChristina V Obiezu, Shannon J C Shan, Antoninus Soosaipillai, et al.
Molecular Oncology|November 26, 2013
Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludinGeorge S Karagiannis, David F Schaeffer, Chan-Kyung J Cho, et al.
Biological Chemistry|April 22, 2005
Enzymatic profiling of human kallikrein 14 using phage-display substrate technologyLoyse M Felber, Carla A Borgoño, Sylvain M Cloutier, et al.
Molecular & Cellular Proteomics : MCP|June 27, 2013
Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissuesHari Kosanam, Ioannis Prassas, Caitlin C Chrystoja, et al.
Plos One|May 27, 2020
Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetesJulie A D Van, Sergi Clotet-Freixas, Anne-Christin Hauschild, et al.
Pageof 79